Silexion Therapeutics LTD

NASDAQ: SLXNW · Real-Time Price · USD
0.07
0.00 (1.01%)
At close: Jun 09, 2025, 9:30 AM

Silexion Therapeutics LTD Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q1 2023 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Mar 31, 2023 Mar 31, 2021
Net Income
-1.74M -1.75M -11.86M -1.49M -1.42M -1.68M -809K 313.19K -97.75K
Depreciation & Amortization
4K -12K 22K 7K 8K 6K 10K n/a n/a
Stock-Based Compensation
21K n/a 5.8M 32K 32K 34K 32K n/a n/a
Other Working Capital
n/a 1.35M -947K 263K -386K 422K -180K 223.52K -713.21K
Other Non-Cash Items
n/a -220K 3.82M 83K 136K -47K 107K -4.88K 5.78K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
n/a -947K -430K 302K -505K 430K -25K 223.52K -713.21K
Operating Cash Flow
-2.45M -2.93M -2.65M -1.06M -1.75M -1.26M -685K 531.83K -805.18K
Capital Expenditures
-6K n/a -16K n/a -6K -4K -6K n/a 3.00
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a 78K n/a n/a
Investing Cash Flow
-6K n/a -16K n/a -6K -4K 72K n/a n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a 385K -149.99K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a -90.75M n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
7.43M 2.8M 2.3M n/a n/a n/a n/a n/a -2.55M
Financial Cash Flow
7.43M 2.18M 2.92M n/a n/a n/a n/a -90.37M 116.1M
Net Cash Flow
4.96M -753K 276K -1.08M -1.81M -1.17M -679K n/a n/a
Free Cash Flow
-2.46M -2.93M -2.67M -1.06M -1.76M -1.26M -691K 531.83K -805.18K